Using EdU (Figure 5A–5D) we found that SATB1 overexpression or miR-590-5p inhibition restored glioma cell proliferation ability in both LN229 and U251 cells post hsa_circ_0010889 silencing (Figure 5C–5E). This evidence concerns the gene SATB1 and central nervous system cancer.